Hoag Memorial Hospital Presbyterian
Hoag Memorial Hospital Presbyterian
Explore linked clinical trials.11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Enrolling by invitation | Phase 2 | 2026-09-23 | NCT07344220 | |
| Blood and Cystic Fluid From Patients Undergoing Surgery for Worrisome Pancreatic Cysts | Cysts, Digestive System Diseases, Pancreatic Cyst, neoplasm, pancreas disorder | Recruiting | Not stated | 2026-08-17 | NCT07767227 | |
| Decolonization to Reduce After-Surgery Events of Surgical Site Infection | Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Surgical Wound Infection, Wound Infection | Recruiting | Phase 4 | 2026-07-21 | NCT05586776 | |
| A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT. | Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Not yet recruiting | Phase 2 | 2026-06-09 | NCT07635524 | |
| A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Not stated | 2026-02-04 | NCT03193541 | |
| Sling-Fiber Preservation POEM vs. Conventional POEM for Reducing Post-POEM GERD | Deglutition Disorders, Digestive System Diseases, achalasia, digestive system disorder, duodenal disorder, dyskinesia of esophagus, esophageal disorder, esophagitis, gastroenteritis, gastroesophageal reflux disease, intestinal disorder, peptic esophagitis, peptic ulcer disease, stomach disorder | Not yet recruiting | Not applicable | 2025-10-22 | NCT07178821 | |
| Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Not applicable | 2025-09-15 | NCT03889119 | |
| Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device | Chemotherapy Induced Neuropathic Pain; Chemotherapy Induced Pain Neuropathy; Chemotherapy Induced Peripheral Neuropathy; Chemotherapy Induced Peripheral Neuropathy (CIPN) | Enrolling by invitation | Not applicable | 2025-07-11 | NCT07061769 | |
| A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer | prostate adenocarcinoma | Recruiting | Phase 1 | 2024-12-16 | NCT06736054 | |
| Perioperative Mindfulness Proposal | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Skin and Connective Tissue Diseases, adenocarcinoma, breast cancer, breast carcinoma in situ, breast disorder, breast neoplasm, carcinoma, ductal breast carcinoma in situ, epithelial neoplasm, in situ carcinoma, neoplasm, skin disorder | Recruiting | Not applicable | 2024-10-15 | NCT04049214 | |
| PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2021-07-27 | NCT04700332 |